Tirzepatide injection · Mounjaro®

Mounjaro doses, the savings card, and where weight loss fits

A once-weekly tirzepatide shot with FDA approval for type 2 diabetes. AM Rx providers prescribe it when they judge it appropriate, and our insurance coordination team files the prior authorization.

  • Six strengths, 2.5 mg through 15 mg, stepped up only while blood sugar calls for it
  • As low as $25 a month: the brand Mounjaro copay on a plan that covers it*
  • A licensed provider reviews new intakes in 1 to 2 business days. Starting takes no appointment
  • Eligible adults can join from any of the 50 states or Washington, DC
Zepbound, Ozempic, Mounjaro and Wegovy injection pens side by side on a green background
Brand Mounjaro: copay from $25/mo on plans that cover it*
Outline of the United States with the words “Compounded by Licensed Pharmacies in the USA”
Compounded tirzepatide, only if prescribed: from $216/mo†
Phone screen asking “What is your desired weight?” beside a medication recommendation card
A licensed provider evaluates every intake
$25/moLowest copay for brand Mounjaro, on a plan that covers it*
$39Month one of AM Rx membership
$216/moCompounded tirzepatide bought as a 3-month supply, if prescribed†
Which conditions is Mounjaro approved for?

Only type 2 diabetes. FDA approval first came on May 13, 2022, for adults who need better blood sugar control alongside diet and exercise.1 Since then the label has added children from age 10, and a second use: cutting the chance of heart attack, stroke and cardiovascular death in adults with type 2 diabetes whose risk is high.2 Weight loss is not on the list. For that, the FDA approved the same ingredient as Zepbound®.

What does off-label mean for Mounjaro and weight loss?

Off-label means prescribing a medicine for something its FDA label does not list, and Mounjaro for weight loss alone is one such case.2 Two consequences: your plan may decline to pay, and Eli Lilly’s savings card will not apply, since it is valid only for uses on the label.3

*Coverage and copay are your insurer’s call, and approval is not guaranteed. The Mounjaro Savings Card is a separate Eli Lilly program. †A single month costs $329; $216 a month is the 3-month-supply price. Shipping is in both. Compounded drugs have no FDA approval, and the agency does not review their safety, effectiveness or quality. Membership is billed apart from medication.

Safety summary: Serious side effects are possible with Mounjaro, among them thyroid tumors that may be cancerous. People who have had medullary thyroid carcinoma (MTC), or whose relatives have, must not take it. Nor should anyone with the syndrome MEN 2. Full safety information.

Mounjaro and weight loss: what the trials measured

Across the five diabetes trials printed on Mounjaro’s label, the average adult ended 11.9 to 24.9 pounds lighter (5.4 to 11.3 kg) after 40 to 52 weeks, depending on dose and on the other diabetes medicines in use. A1C dropped by 1.7 to 2.4 points.2

For a percentage, the slider borrows from SURMOUNT-2. That study ran for 72 weeks and tested tirzepatide for weight management in 938 people who all had type 2 diabetes and whose BMI was 27 or higher. Mean weight loss was 12.8% at 10 mg and 14.7% at 15 mg. Placebo: 3.2%.4 It supports Zepbound’s approval, not Mounjaro’s.

Loss at SURMOUNT-2’s
15 mg mean, 14.7%
37lbs

Using both doses studied, 10 mg and 15 mg: 32 to 37 lbs

A calculation, not a prediction: your weight multiplied by a single study’s mean. Diet and activity counseling was part of that study,5 individual results differ, and weight loss is not an approved use of Mounjaro.

Pounds lost in each Mounjaro diabetes trial

TrialWeeksWeight change at 5, 10, 15 mgCompared with
SURPASS-1 (no other diabetes medicine)40−13.9, −15.4, −17.2 lbPlacebo, −2.2 lb
SURPASS-2 (with metformin)40−16.8, −20.5, −24.7 lbSemaglutide 1 mg, −12.6 lb
SURPASS-3 (with metformin; some also took an SGLT2 inhibitor)52−15.4, −21.2, −24.9 lbInsulin degludec, +4.2 lb
SURPASS-4 (with 1 to 3 oral medicines)52−14.1, −19.6, −23.4 lbInsulin glargine, +3.7 lb
SURPASS-5 (with basal insulin)40−11.9, −16.5, −19.4 lbPlacebo, +3.5 lb

Mean changes from the prescribing information, with kilograms converted to pounds by us.2 Eli Lilly funded SURPASS-2, and participants knew which drug they were taking.6 See our Mounjaro vs Ozempic® guide.

Mounjaro vs Zepbound: one drug, two FDA labels

Eli Lilly sells tirzepatide under both names. Each has its own FDA-approved uses, and those uses steer insurance coverage and savings card eligibility.

FeatureMounjaroLabel: type 2 diabetesZepboundLabel: weight and sleep apneaCompounded tirzepatideNo FDA approval
Approved usesType 2 diabetes, ages 10 and up. Also lowering heart attack and stroke risk for high-risk adults who have type 2 diabetes2Chronic weight management for adults with obesity, or with overweight plus a related health condition. Also moderate to severe obstructive sleep apnea alongside obesity5None. Compounded drugs get no FDA review of safety, effectiveness or quality7
For weight lossOff-labelOn-labelThe FDA’s position: reserve compounded drugs for patients whose medical needs no approved drug can meet7
Lilly savings cardYes, for on-label prescriptions with commercial insurance. Expires December 31, 20263A different card. See our Zepbound pageNot applicable
Medication cost with AM RxYou pay your own pharmacy. On a plan that covers the brand, a copay may be as little as $25 a month$329 for one month, or a 3-month supply from $216 a month. Home delivery included
AM Rx membershipMonth one is $39. After that it is $135 a month. Medication is extra.

What tirzepatide does in the body

Tirzepatide is one molecule built to activate two hormone receptors: GIP and GLP-1. At approval, the FDA described Mounjaro as first in its class.1 Ozempic and Wegovy® contain semaglutide, which targets GLP-1 only.6

The drug makes the pancreas put out more insulin while glucose is raised, cuts glucagon, delays the emptying of the stomach and leaves people eating less.5 Its half-life is about five days, and it is dosed once a week.2

Key points

  • Type 2 diabetes is the approved use. Weight loss on its own is off-label.
  • Zepbound is the identical ingredient in identical strengths.
  • Thyroid C-cell tumors are the subject of its boxed warning.

Getting a Mounjaro prescription online with AM Rx

Everything starts with a health questionnaire. A licensed provider evaluates it, and visits are optional.

Sign-up to first dose, in five stages
1. Complete the questionnaire

Joining costs $39 for month one. In the intake, give your diagnoses, your latest A1C if you have one, and all current medicines, insulin and sulfonylureas above all.

Phone screen asking “What is your desired weight?” beside a medication recommendation card
2. A provider evaluates your answers

Reviews are done by physicians and nurse practitioners who hold U.S. licenses and board certification. Expect a reply by secure message in 1 to 2 business days, saying whether Mounjaro, another medication or none is appropriate. Video and phone visits come with membership.

Hands holding a phone that shows a message thread with a provider
3. Prior authorization goes to your plan

When the prescription is for a brand-name drug, our insurance coordination team files the request. Most plans reply in 2 to 14 business days. If the answer is no, the team may resubmit, three requests being the limit. An authorization lasts only while your membership is active.

A man in a knit hat holding a phone and a mug
4. The pharmacy fills it

Brand-name Mounjaro prescriptions go to whichever pharmacy you pick. Compounded tirzepatide, when that is what the provider prescribes, is mailed by a partner pharmacy, typically 2 to 9 business days later. No compounded drug is FDA-approved, and the FDA reviews none of them for safety, effectiveness or quality.

Zepbound, Ozempic, Mounjaro and Wegovy injection pens side by side on a green background
5. Stay in touch between doses

Message the provider and care team as often as you need. A weight loss coach is assigned to you. Mention side effects ahead of your next injection.

A woman laughing while looking at her phone
A woman in workout clothes laughing against a red wall

Inside the AM Rx membership

  • Intake review by a licensed provider, who prescribes only if medication is appropriate
  • Prior authorizations for brand-name drugs, filed by our insurance coordination team
  • Secure messages to your provider and care team, with no cap
  • Monthly visits by video or phone, if you choose to have them
  • Your own weight loss coach, plus the AM Rx app and web portal
$39Month one
$135/moEvery month after

Medication costs extra. Cancel in the portal whenever you like. HSA and FSA cards are accepted.

Get Started

Mounjaro side effects by dose

Nausea tops the list. On the label, 12%, 15% and 18% of adults reported it at the 5, 10 and 15 mg doses, versus 4% of those given placebo.2

Reported by15 mg10 mg5 mgPlacebo
Nausea18%15%12%4%
Diarrhea17%13%12%9%
Reduced appetite11%10%5%1%
Vomiting9%5%5%2%
Constipation7%6%6%1%
Indigestion (dyspepsia)5%8%8%3%
Abdominal pain5%5%6%4%

Pooled results from two placebo-controlled trials, SURPASS-1 and SURPASS-5, in adults with type 2 diabetes.2

How long Mounjaro side effects last

The label gives no timetable in days or weeks. It says nausea, vomiting and diarrhea came mostly during the dose increases and grew less frequent afterward. Digestive side effects made 3.0% (5 mg), 5.4% (10 mg) and 6.6% (15 mg) of patients quit, versus 0.4% of the placebo group.2

Low blood sugar

With Mounjaro as the only diabetes drug, blood sugar below 54 mg/dL was recorded in 0% of patients at every dose and in 1% on placebo. Alongside basal insulin the rates were 16%, 19% and 14%, with placebo at 13%.2 For the whole drug class, see GLP-1 side effects.

What can help

  • Smaller meals, more often. While you feel sick early in treatment, cut back on fatty and high-fiber foods.8
  • Fluids. Prolonged vomiting or diarrhea causes dehydration, which can injure the kidneys.2,9
  • Time. Ask whether your next increase can wait. Four weeks is a minimum.

Symptoms that need urgent care

  • Stomach pain that is severe, does not ease and may be felt in the back, with vomiting or without it9
  • Swelling in the face, lips, tongue or throat, a severe rash, or problems breathing or swallowing9
  • Pain high in the abdomen along with fever, jaundice or pale, clay-colored stools9
  • Vision that suddenly fails in one eye10
  • A neck lump, a persistently hoarse voice or difficulty swallowing (see the boxed warning)

Mounjaro doses, step by step: 2.5 mg up to 15 mg

The first Mounjaro dose is always 2.5 mg, taken weekly. Increases come in 2.5 mg steps. Each requires four weeks or more at the previous dose, and each is optional: the label calls for it only when blood sugar is not yet controlled. Adults stop at 15 mg.2

Dose per weekEarliest startNotes
2.5 mgDay oneThe starting dose for all patients.
5 mgAfter 4 weeks of treatmentFirst possible increase.
7.5 mgAfter 8 weeksSecond possible increase.
10 mgAfter 12 weeksThe limit for anyone under 18.
12.5 mgAfter 16 weeksAdult dosing from here up.
15 mgAfter 20 weeksThe limit for adults.
  1. 2.5 mgStart
  2. 5 mgStep 1
  3. 7.5 mgStep 2
  4. 10 mgStep 3
  5. 12.5 mgStep 4
  6. 15 mgStep 5

The quickest route the August 2026 label allows, derived by us from its four-week minimum at every dose.2 Your provider may hold a dose for longer, or never raise it.

The August 2026 change to Mounjaro’s dosing instructions

The December 2025 label called 2.5 mg a dose for starting treatment, not for glycemic control, and told prescribers to increase to 5 mg once four weeks had passed.11 The August 2026 revision removed both statements. The current text: begin at 2.5 mg; if glycemic control is still insufficient, go up by 2.5 mg, but not before four weeks at the current dose.2

Zepbound did not change. Its label still treats 2.5 mg as a starter that is not for maintenance, with 5 mg following after four weeks.5

Body weight plays no part in Mounjaro dosing, and neither does kidney or liver function.2 Weight management dosing is on our tirzepatide page. Compounded vials have their own guide, tirzepatide dosing in units.

Injecting Mounjaro

  • Same day every week. The hour and your meals make no difference.
  • Sites: abdomen or thigh. If another person injects for you, the back of your upper arm also works.
  • Move to a new spot every week.
  • On insulin too? Inject them separately. Never mix them, and keep the two sites apart.2

Late doses and switching days

  • Within 4 days (96 hours) of the missed day: inject now.
  • Beyond 4 days: leave that dose out and return to your normal day.2
  • Switching days is fine as long as 72 hours (3 days) or more pass between injections.9
  • Example: a Sunday dose remembered on Wednesday is three days late, so take it. On Friday, skip it.

The Mounjaro pen, and three other forms in the label

FormContentsPer cartonAvailability, November 2026
Single-dose pen0.5 mL, one dose, then discard4 pens (28 days)Sold through LillyDirect® and covered by the savings card. No other form is3,12
Single-dose vial0.5 mL, one dose, drawn into a syringe1 vialLabel only
Multi-dose vialFour 0.6 mL doses1 vialLabel only
KwikPen®Four 0.6 mL doses for a single patient1 penLabel only

All four forms come in six strengths.2 “Label only” means absent from Lilly’s Mounjaro ordering and savings pages, with no Lilly source confirming US pharmacy supply.

  • Single-dose pens and vials: fridge storage, between 36°F and 46°F, with the carton on to block light. Never frozen. Unrefrigerated at 86°F or below, the limit is 21 days altogether.
  • KwikPen and multi-dose vial: after first use, throw away at 30 days or after the fourth weekly dose, whichever is sooner.2,9
  • Never shared: a KwikPen is for one person, new needle or not.

Mounjaro Savings Card rules and what Mounjaro costs

$1,112.16 buys four Mounjaro pens at list price (November 2026).13 Your own price turns on three questions: is your insurance commercial, does it cover Mounjaro, and is the prescription for type 2 diabetes?

Your coverageLikely priceNotes
Commercial insurance, Mounjaro covered$25 a fill at best, using Lilly’s savings cardThe prescription has to be on-label. Card contribution capped at $150 a month.
Commercial insurance, Mounjaro not covered$499 a month at best, using the cardSame condition. Card contribution capped at $647 a month.
Uninsured, or paying cash by choice$499 a month and up at LillyDirectFor the single-dose pen at every strength, before any taxes and fees.12
Medicaid, Medicare, VA or TRICAREWhatever your plan charges. The savings card is barredBy Lilly’s figures, roughly four in five Medicare Part D patients pay $50 or less for 28 days of Mounjaro. The rest average about $262.3
A weight loss prescription without type 2 diabetesCash price, unless your plan chooses to cover itOff-label, which rules out the savings card.

Lilly’s prices and terms, read on November 19, 2026.3 The savings card stops on December 31, 2026 for both tiers, and no 2027 terms had been published.

What Mounjaro costs with insurance

On a commercial plan that covers Mounjaro for type 2 diabetes, your price is the plan’s copay or coinsurance minus the savings card’s contribution. KFF’s annual employer survey notes that plans have generally paid for these drugs in diabetes. For weight loss, just 18% of firms with at least 200 employees reported coverage under their largest plan in 2026.14

Should your plan require prior authorization, AM Rx’s coordination team files it. The insurer decides, and nobody can guarantee a yes. Try our GLP-1 insurance checker.

Mounjaro Savings Card terms through December 31, 2026

Eli Lilly runs the Mounjaro Savings Card as a copay program. It is not insurance. There are two tiers, and your commercial plan’s coverage decision picks the tier.3

TermCovered tierYour plan pays for MounjaroNon-covered tierYour plan does not
Your price$25 a fill at best$499 a fill at best
Days per fill28, 56 or 84 (4, 8 or 12 pens at most)28 (4 pens at most)
Most the card contributes per fill$150, $300 or $450$647
Yearly cap$1,950$8,411
Fills allowed each calendar year13
ExpiryDecember 31, 2026. Lilly reserves the right to amend or end the card earlier with no notice.

Savings card math: when $25 becomes more

Treat $25 as the floor. Beyond the card’s cap, the bill is yours. Three cases, calculated by us from Lilly’s caps:

  • $60 copay. Lilly contributes $35. You are charged $25.
  • $210 copay. Lilly contributes its $150 maximum. You are charged $60.
  • An 84-day fill. The maximum becomes $450, and only one of your 13 fills is used.

Mounjaro Savings Card eligibility

All four conditions apply at every fill:3

  • It is the single-dose pen that is prescribed, and for an FDA-labeled use. Each labeled use involves type 2 diabetes.2
  • You carry commercial drug insurance.
  • You have no state, federal or other government-funded coverage. Lilly’s list: Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA and TRICARE.
  • You are an adult (18 or over) residing in the U.S. or Puerto Rico.

The card is refused for prescriptions written purely for weight loss, for people with no insurance, for vials and the KwikPen, and when combined with another Mounjaro coupon or discount card.

Getting the card and using it

  1. With an on-label prescription in hand, go to mounjaro.lilly.com/savings-coverage, press “Get Savings Card” and complete the attestation questions.3
  2. Activate it, then hand it over at the pharmacy along with your insurance card.
  3. Want 84 days in one fill? The prescription must say so, and both plan and pharmacy must permit it.
  4. Unexpected price? Have the pharmacist reprocess the card, or phone Lilly Support Services on 1-800-545-5979.

What Mounjaro costs without insurance

Uninsured buyers face either the $1,112.16 list price or Lilly’s self-pay offer at LillyDirect: $499 a month to start, whichever strength of the single-dose pen is prescribed.12,13 The savings card is out, since commercial insurance is a condition.

Medicare, Medicaid and Mounjaro

No manufacturer savings card, Mounjaro’s included, can be used by someone with Medicaid, Medicare, VA, TRICARE or other government coverage.3 Lilly states that many Medicare Part D plans include Mounjaro for type 2 diabetes. The Medicare GLP-1 Bridge is a weight management program, and Mounjaro is not in it.15 State Medicaid programs are required to cover GLP-1 medicines for diabetes.16

AM Rx pricing

  • Membership. $39 in month one, $135 in each later month, medication not included.
  • Brand-name Mounjaro. Paid at your pharmacy. If your plan covers it, the copay may be as little as $25 a month.
  • Compounded tirzepatide, only if prescribed. $329 for one month, or from $216 a month as a 3-month supply, shipped free. It is a different product from Mounjaro, has no FDA approval, and gets no FDA review of its safety, effectiveness or quality.

Hoping to use Mounjaro for weight loss? Absent type 2 diabetes, that prescription would be off-label and the savings card would not apply. The tirzepatide product with a weight management approval is Zepbound. Our tirzepatide near me guide lists other routes.

Buying Mounjaro from LillyDirect

LillyDirect, the manufacturer’s own pharmacy channel, sells the single-dose Mounjaro pen to self-pay customers at $499 a month and up, with free delivery or retail pharmacy pickup.12 It fills prescriptions. It does not write them.

QuestionAM RxLillyDirect
PrescribingYes, if a provider judges a medication appropriateNone. A licensed clinician elsewhere sends the prescription
Insurance and MounjaroPrior authorization filed by the coordination teamSelf-pay only, in Lilly’s words3
What Mounjaro costsYour pharmacy copay, which may be as little as $25 a month if covered$499 a month and up
Dosing and side effect questionsAnswered by your provider and care team in messagesGo back to your prescriber

LillyDirect column: Lilly’s website, November 19, 2026. AM Rx is independent of Eli Lilly and of LillyDirect.

Mounjaro next to Zepbound, Ozempic and Wegovy

Two of the four are diabetes medicines (Mounjaro, Ozempic) and two are approved for weight (Zepbound, Wegovy).

FeatureMounjaroZepboundOzempicWegovy
IngredientTirzepatideTirzepatideSemaglutideSemaglutide
FDA label coversType 2 diabetes (ages 10 and up); heart attack and stroke risk in high-risk adults who have type 2 diabetes2Chronic weight management in adults; obstructive sleep apnea alongside obesity5Type 2 diabetes in adults; cardiovascular risk when heart disease is also present; kidney decline when chronic kidney disease is also present17Weight management (ages 12 and up); cardiovascular risk in adults with heart disease and excess weight; the liver disease MASH in adults18
Weight lossOff-labelApproved useOff-labelApproved use
Dose each week2.5 mg up to 15 mgSame as Mounjaro0.25 mg up to 2 mg0.25 mg up to 2.4 mg; some adults go to 7.2 mg. A daily tablet also exists
AM Rx members

AM Rx members describe the program

One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
Michelle, 33 | Lost 48 pounds
I started semaglutide at the recommendation of my AM Rx provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Michael, 37 | Lost 29 pounds
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and AM Rx was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Susanne, 60 | Lost 33 pounds
Since I started AM Rx, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
Rachel | AM Rx Member
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
John | AM Rx Member
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Sara | AM Rx Member

Individual results may vary. These reviews describe the experience of individual AM Rx members and do not promise any result. Medication is prescribed only if a licensed provider considers it appropriate.

A man at home smiling at his laptop
Your care team

The diagnosis comes first, then the dose

Because Mounjaro is a type 2 diabetes medicine, an AM Rx provider begins with what you are treating. When Zepbound or something else matches your history better, you will hear that, with the reasons.

50 states and DCU.S.-licensed physicians and nurse practitioners, wherever you live
No appointment to bookA provider reads your intake online and replies by secure message
Open every dayPhone support Monday to Friday 9am to 8pm ET, weekends 12pm to 8pm ET

The AM Rx care team checks the medical content of this page against FDA prescribing information and published clinical trials. It is general health education and does not replace advice from your own provider.

Mounjaro questions, answered

Has the FDA approved Mounjaro for weight loss?

It has not. The label’s uses are glycemic control in type 2 diabetes from age 10, plus a lower risk of heart attack and stroke for high-risk adults who have that diagnosis.2 A prescription written purely for weight loss is therefore off-label. Tirzepatide’s weight management approval belongs to a second brand name, Zepbound.5

Does insurance pay for Mounjaro when you do not have diabetes?

Often it will not. KFF reports that plans generally pay for GLP-1 drugs in diabetes, yet in 2026 just 18% of large employers had weight loss coverage in their biggest plan.14 A Mounjaro request for weight loss is off-label as well. Our coordination team can file a prior authorization, but approval is the insurer’s decision.

What dose of Mounjaro do you start on, and what is the maximum?

You start on 2.5 mg a week. Adults can go as high as 15 mg weekly, and anyone under 18 stops at 10 mg. Each increase is 2.5 mg, is made only when blood sugar remains too high, and must wait four weeks or more.2 So 15 mg cannot begin before week 21. See the dose table.

Does the Mounjaro dose have to go up every four weeks?

It does not. Four weeks is the least time allowed at a dose, and the label sets no deadline for moving on.2 Each increase depends on blood sugar still being too high. Labels before August 2026 told prescribers to move to 5 mg at the four-week mark. The current one dropped that line.11

How late can a missed Mounjaro dose be taken?

Up to 4 days, or 96 hours, after your scheduled day. Inside that window, inject when you remember. Outside it, leave the dose out and wait for your normal day.2 Any two injections need 3 days or more between them.9 After more than one missed dose, check with your provider before you restart.

Does the Mounjaro Savings Card cover a 3-month prescription?

It does. On a commercial plan that covers Mounjaro, the card applies to fills of 28, 56 or 84 days, and an 84-day fill can cost you as little as $25.3 First, though, the prescription must be written for three months, and your plan and pharmacy must both agree to dispense that much.

Why am I paying more than $25 with the Mounjaro Savings Card?

Start with the cap. On the covered tier Lilly contributes no more than $150 per 28-day fill, so once your copay passes $175 your share climbs above $25.3 Two other explanations: your prior authorization was denied, which drops you to the $499 tier, or you have used up the year’s $1,950 or 13 fills.

Can people on Medicare, Medicaid or TRICARE use the Mounjaro Savings Card?

They cannot. The terms shut out everyone with state, federal or other government-funded coverage. Lilly spells out Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA and TRICARE.3 Anyone who switches to such a plan mid-year has to stop using the card at that point.

Important safety information

Boxed warning: thyroid C-cell tumor risk

Rats given tirzepatide developed thyroid C-cell tumors. Whether Mounjaro does the same in humans is unknown, and that includes the thyroid cancer medullary thyroid carcinoma (MTC). Never use Mounjaro if you have had MTC, if a relative has had it, or if you have MEN 2 (Multiple Endocrine Neoplasia syndrome type 2). Report a neck lump or swelling, a hoarse voice that persists, difficulty swallowing or breathlessness to your provider.2

Who must not take Mounjaro

  • Anyone with MEN 2, or with MTC in their own or their family’s history.
  • Anyone whose reaction to tirzepatide, or to another ingredient in Mounjaro, was a serious allergy.

What your provider needs to know first

  • Past or present pancreas problems.
  • Gastroparesis (a stomach that empties slowly) or other severe digestive trouble.
  • Diabetic retinopathy at any time.
  • Other diabetes medicines you take, above all insulin or a sulfonylurea.
  • Planned surgery, or any procedure involving anesthesia or deep sedation.
  • Pregnancy, plans for pregnancy, or breastfeeding. The effect of Mounjaro on an unborn baby is unknown.
  • Use of birth control pills. A non-oral or barrier method is advised during the 4 weeks following the first dose and each increase.9

A summary cannot stand in for the complete label. Lilly publishes the Prescribing Information and the Medication Guide. To report a side effect, use fda.gov/medwatch or phone 1-800-FDA-1088.

Sources

  1. FDA. FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes. Bulletin sent May 13, 2022. https://content.govdelivery.com/accounts/USFDA/bulletins/317b871
  2. Mounjaro (tirzepatide) Prescribing Information. Eli Lilly and Company. Revised 08/2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
  3. Eli Lilly and Company. Mounjaro Savings & Coverage, with the Savings Card terms and conditions. https://mounjaro.lilly.com/savings-coverage
  4. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626. https://pubmed.ncbi.nlm.nih.gov/37385275/
  5. Zepbound (tirzepatide) Prescribing Information. Eli Lilly and Company. Revised 08/2026. https://pi.lilly.com/us/zepbound-uspi.pdf
  6. Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021;385(6):503-515. https://pubmed.ncbi.nlm.nih.gov/34170647/
  7. FDA. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  8. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory. Obesity (Silver Spring). 2025;33(8):1475-1503. https://pubmed.ncbi.nlm.nih.gov/40445127/
  9. Mounjaro (tirzepatide) Medication Guide. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/mounjaro-us-mg.pdf
  10. FDA. FDA Requires Safety Labeling Changes for GLP-1 Receptor Agonists Due to Potential Increased Risk of Rare But Serious Eye Condition. November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential
  11. Mounjaro (tirzepatide) Prescribing Information as approved 12/2025 (NDA 215866/S-039). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215866s039lbl.pdf
  12. Eli Lilly and Company. Mounjaro through LillyDirect. https://www.lilly.com/lillydirect/medicines/mounjaro
  13. Eli Lilly and Company. Mounjaro cost information (list price). https://pricinginfo.lilly.com/mounjaro
  14. KFF. 2026 Employer Health Benefits Survey. https://www.kff.org/health-costs/2026-employer-health-benefits-survey/
  15. Medicare.gov. Weight loss drugs (Medicare GLP-1 Bridge). https://www.medicare.gov/coverage/weight-loss-drugs
  16. KFF. Medicaid Coverage of and Spending on GLP-1s. January 16, 2026. https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/
  17. Ozempic (semaglutide) Prescribing Information. Novo Nordisk. Revised 05/2026. https://www.novo-pi.com/ozempic.pdf
  18. Wegovy (semaglutide) Prescribing Information. Novo Nordisk. Revised 06/2026. https://www.novo-pi.com/wegovy.pdf

Reviewed by the AM Rx care team. Sources opened November 19, 2026. Prices and program terms reflect November 2026.

Ask a licensed provider about Mounjaro

Send in the online intake and a provider will reply by secure message. Membership is $39 for month one.

Get Started